Literature DB >> 2192184

[Effect of cepharanthin on radiotherapy induced leukopenia].

T Ohta1, K Morita.   

Abstract

Cepharanthin, a kind of alkaloid, has been reported to show a protective effect for leukopenia induced by radiation therapy. In this study, one of three kinds of drugs, Cepharanthin, S-Adchnon (adrenochrome derivative) and Hythiol (L-cysteine), was randomly administered to 94 patients with cancer of the head and neck, the uterine cervix and the lung, during the course of radiotherapy. When Cepharanthin was given, 81.3% of the patients were protected from leukopenia, compared with 51.6% in S-Adchnon and 32.3% in Hythiol. It is suggested that prophylactic use of Cepharanthin may be useful for cancer radiotherapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2192184

Source DB:  PubMed          Journal:  Rinsho Hoshasen        ISSN: 0009-9252


  8 in total

1.  Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' disease.

Authors:  Cheuk Wun Li; Roman Osman; Francesca Menconi; Erlinda Concepcion; Yaron Tomer
Journal:  J Autoimmun       Date:  2020-01-21       Impact factor: 7.094

2.  Cepharanthine Ameliorates Chondrocytic Inflammation and Osteoarthritis via Regulating the MAPK/NF-κB-Autophagy Pathway.

Authors:  Minjun Yao; Caihua Zhang; Lingzhi Ni; Xiaoxiao Ji; Jianqiao Hong; Yazhou Chen; Jie Wang; Congsun Li; Jiyan Lin; Tingting Lu; Yihao Sheng; Menghao Sun; Mingmin Shi; Chenhe Zhou; Xunzi Cai
Journal:  Front Pharmacol       Date:  2022-06-21       Impact factor: 5.988

Review 3.  Genetics and epigenetics of autoimmune thyroid diseases: Translational implications.

Authors:  Hanna J Lee; Mihaela Stefan-Lifshitz; Cheuk Wun Li; Yaron Tomer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2022-04-11       Impact factor: 5.667

4.  Biscoclaurine alkaloid cepharanthine protects DNA in TK6 lymphoblastoid cells from constitutive oxidative damage.

Authors:  Dorota Halicka; Masamichi Ita; Toshiki Tanaka; Akira Kurose; Zbigniew Darzynkiewicz
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

5.  Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.

Authors:  Masamichi Ita; H Dorota Halicka; Toshiki Tanaka; Akira Kurose; Barbara Ardelt; Kuslima Shogen; Zbigniew Darzynkiewicz
Journal:  Cancer Biol Ther       Date:  2008-04-19       Impact factor: 4.742

6.  Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis.

Authors:  Cheuk Wun Li; Francesca Menconi; Roman Osman; Mihaly Mezei; Eric M Jacobson; Erlinda Concepcion; Chella S David; David B Kastrinsky; Michael Ohlmeyer; Yaron Tomer
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

7.  Cepharanthine Blocks Presentation of Thyroid and Islet Peptides in a Novel Humanized Autoimmune Diabetes and Thyroiditis Mouse Model.

Authors:  Cheuk Wun Li; Roman Osman; Francesca Menconi; Larissa C Faustino; Kookjoo Kim; Oliver B Clarke; Hanxi Hou; Yaron Tomer
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

8.  Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption.

Authors:  Chen-He Zhou; Jia-Hong Meng; Yu-Te Yang; Bin Hu; Jian-Qiao Hong; Zheng-Tao Lv; Kun Chen; Boon Chin Heng; Guang-Yao Jiang; Jian Zhu; Zhao-Hui Cheng; Wei Zhang; Le Cao; Wei Wang; Wei-Liang Shen; Shi-Gui Yan; Hao-Bo Wu
Journal:  Front Pharmacol       Date:  2018-03-27       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.